| Ident. | Authors (with country if any) | Title |
|---|
| 000029 (2011) |
Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon] | Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma |
| 000039 (2011) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon] | Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders |
| 000056 (2015) |
Yuliya Hellwig [Allemagne] ; Young E. Yoo [Allemagne] ; Marie L. Re [Allemagne] ; Oliver Andres [Allemagne] ; Matthias Braun [Allemagne] ; Paul G. Schlegel [Allemagne] ; Matthias Wölfl [Allemagne] | Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab |
| 000057 (2007) |
Peter Taylor [Royaume-Uni] | IL‐6 inhibition in the treatment of rheumatoid arthritis |
| 000058 (2014) |
Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. Moertel | Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance |
| 000069 (2016) |
Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon] | Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary |
| 000095 (2009) |
Paul Emery ; Rhonda Siddall | Tocilizumab — IL‐6 inhibition for the treatment of rheumatoid arthritis |
| 000119 (2012) |
Steve Chaplin ; Chadi Rakieh ; Philip Conaghan | Biologic drugs: properties and use in the treatment of RA |
| 000172 (2011) |
Maneesh Gogia [États-Unis] ; Daniel E. Furst [États-Unis] | Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation |
| 000265 (2009) |
Margaret Hy [Royaume-Uni] ; Ernest Hs Choy [Royaume-Uni] | Certolizumab pegol: a new option for rheumatoid arthritis |
| 000290 (2011) |
Yiyun Yu [États-Unis, République populaire de Chine] ; Antonio La Cava [États-Unis] | Current drugs in systemic lupus erythematosus |
| 000326 (2015) |
Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon] | Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model |
| 000548 (2010) |
Elena Nikiphorou ; Adam Young | RA: overview of recommended diagnosis and drug treatment |
| 000570 (2012) |
Zhifeng Wei [République populaire de Chine] ; Fengyun Wang [République populaire de Chine] ; Jie Song [République populaire de Chine] ; Qian Lu [République populaire de Chine] ; Peng Zhao [République populaire de Chine] ; Yufeng Xia [République populaire de Chine] ; Guixin Chou [République populaire de Chine] ; Zhengtao Wang [République populaire de Chine] ; Yue Dai [République populaire de Chine] | Norisoboldine inhibits the production of interleukin‐6 in fibroblast‐like synoviocytes from adjuvant arthritis rats through PKC/MAPK/NF‐κB‐p65/CREB pathways |
| 000576 (2013) |
Marco Bigoni [Italie] ; Paola Sacerdote [Italie] ; Marco Turati [Italie] ; Silvia Franchi [Italie] ; Marta Gandolla [Italie] ; Diego Gaddi [Italie] ; Sarah Moretti [Italie] ; Daniele Munegato [Italie] ; Carlo A. Augusti [Italie] ; Elena Bresciani [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie] | Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury |
| 000584 (2012) |
Chia Chi Sun [États-Unis] ; Valentina Vaja [États-Unis, Italie] ; Jodie L. Babitt [États-Unis] ; Herbert Y. Lin [États-Unis] | Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation |
| 000922 (2011) |
Steve Chaplin ; Andrew Ostor | Golimumab: once‐monthly injection for rheumatic conditions |
| 000A87 (2011) |
Rajkumar Venkatramani [États-Unis] ; Nina S. Ma [États-Unis] ; Pisit Pitukcheewanont [États-Unis] ; Marcio H. Malogolowkin [États-Unis] ; Leo Mascarenhas [États-Unis] | Gorham's disease and diffuse lymphangiomatosis in children and adolescents |
| 000B67 (2012) |
Sandeep Kumar [États-Unis] ; Mark A. Mitchell [États-Unis] ; Bonita Rup [États-Unis] ; Satish K. Singh [États-Unis] | Relationship between potential aggregation‐prone regions and HLA‐DR‐binding T‐cell immune epitopes: Implications for rational design of novel and follow‐on therapeutic antibodies |
| 000C02 (2011) |
Ines Zidi [Tunisie, Arabie saoudite] ; Wissem Mnif [Tunisie] ; Aicha Bouaziz [Tunisie] ; Nidhal Ben Amor [Tunisie, Arabie saoudite] | Certolizumab pegol therapy of rheumatoid arthritis: Overview |
| 000E98 (2008) |
S. Koshiba [Japon] ; S. Ichimiya [Japon] ; T. Nagashima [Japon] ; A. Tonooka [Japon] ; T. Kubo [Japon] ; T. Kikuchi [Japon] ; T. Himi [Japon] ; N. Sato [Japon] | Tonsillar crypt epithelium of palmoplantar pustulosis secretes interleukin‐6 to support B‐cell development via p63/p73 transcription factors |
